Dr Muntadhar Al Moosawi

Dr Al Moosawi brings almost nine years of expertise in Hematopathology.

Dr Al Moosawi earned his Doctor of Medicine (MD) degree from Oman Medical College in 2014. Following this, he initially had his residency training in Hematopathology at Oman Medical Specialty Board from 2015 to 2017. Dr. Al Moosawi then moved to Canada and continued his further specialty residency training in Hematological Pathology from 2017 to 2021 at the University of British Columbia, Canada.
Furthering his specialization at the same university, Dr. Al Moosawi successfully completed a Clinical Fellowship in Coagulation from 2021 till 2022, an area of medicine that focuses on studying blood clotting and related disorders. This specialized training equipped him with qualifications and a nuanced understanding of coagulation.

Dr Al Moosawi has been awarded the Board Certificate in Hematological Pathology in 2021 from the Royal College of Physicians and Surgeons of Canada (RCPSC). He has also been a Fellow of the Royal College of Physicians and Surgeons of Canada (FRCPSC) since 2021. Dr. Al Moosawi also holds a master’s degree in health science (MHSc) from the University of British Columbia, with a focus on research methodology and statistics. Dr. Al Moosawi's interest in research has led him to spearhead and contribute to numerous research initiatives, primarily focused on the study and management of both congenital and acquired blood disorders in general and bleeding disorders specifically. His keen interest in laboratory coagulation diagnostics has culminated in a series of significant publications. These works predominantly revolve around the investigation and management of bleeding disorders, employing advanced viscoelastic testing techniques such as ROTEM and TEG, mainly to identify predictors of bleeding through these advanced testing methods and to optimize blood management in different patient populations, through the utilization of ROTEM/TEG-guided transfusion algorithms. His contributions in this domain have been influential in enhancing the understanding and treatment of these complex conditions.

Prior to joining the National Reference Laboratory, Dr Al Moosawi worked as a Hematopathologist at the Royal Hospital (Ministry of Health, Sultanate of Oman). He is a trainer in the Oman Specialty Board for the Hematopathology program. Dr Al Moosawi is also serving as the deputy chair of the examination sub-committee of the Hematopathology residency program and an active member of the Royal hospital research committee.

Dr Al Moosawi’s scope of practice includes General Hematopathology, Diagnostics of coagulation, Viscoelastic testing (ROTEM/TEG), Bleeding disorders, Transfusion medicine, Leukemia and lymphoma, Myelodysplastic neoplasms and Myeloproliferative neoplasms.

Field of Expertise

• General hematopathology
• Diagnostics of coagulation
• Transfusion medicine
• Hematological malignancies

Awards & Accreditation

• Doctor of Medicine (MD)
• Board Certificate in Hematological Pathology, RCPSC
• Fellow of the Royal College of Physicians and Surgeons of Canada (FRCPSC)
• Best trainer award in the Hematopathology residency program - Oman Medical Specialty Board, Oman, 2024
• Abstract achievement award at the 61st ASH meeting and exposition in Orlando, USA for the abstract titled "The Use of Chromogenic Factor VIII Assay Changes Treatment Approach in a Portion of Mild Hemophilia A Patients with Factor VIII Assay Discrepancy", December 2019.
• Outstanding abstract award at the 2019 AABB meeting in San Antonio, USA for the abstract titled "Introduction of ROTEM Testing Significantly Reduces Frozen Plasma Transfusion Rates in Liver Transplant Patients", October, 2019.